Magnolioside
CAS: 20186-29-2
Ref. 3D-VAA18629
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 2H-1-Benzopyran-2-one, 6-(b-D-glucopyranosyloxy)-7-methoxy-
- 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-methoxy-
Magnolioside is a bioactive compound that has been shown to have potent anti-inflammatory effects. It has been shown to inhibit the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin-1β (IL-1β), by inhibiting the activation of nuclear factor kappa B (NFκB). Magnolioside also inhibits the production of cyclooxygenase-2 (COX-2) and reduces the production of prostaglandins. This compound also has neuroprotective effects and was found to be effective against radiation-induced cognitive impairment in rats. Magnolioside is cytotoxic to cancer cells, including colorectal cancer cell lines, and may be a potential anticancer agent for colon cancer. The mechanism by which Magnolioside exerts its cytotoxic effect on cancer cells is not well understood; however, it may involve modulation of cellular signaling pathways or inhibition of
Propiedades químicas
Consulta técnica sobre: 3D-VAA18629 Magnolioside
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
